Skip to main content

Table 1 Analyses, study populations and case definitions

From: Non-pharmaceutical interventions and risk of COVID-19 infection: survey of U.K. public from November 2020 – May 2021

Analysis

Casesa

Comparison group

Time window for NPIs

Primary

Probable COVID-19

Study population excluding cases and those meeting our broader ‘Suspected COVID-19’ definition

2 weeks before questionnaire completion (cases and comparison)

Sensitivity 1

Probable COVID-19, excluding those who reported receiving one or more COVID-19 vaccine doses prior to completing the questionnaire

Study population excluding cases, ‘Suspected COVID-19’, and participants who reported receiving one or more COVID-19 vaccine doses prior to completing the questionnaire

2 weeks before questionnaire completion (cases and comparison)

Sensitivity 2

Suspected COVID-19

Those not meeting case definition

2 weeks before questionnaire completion (cases and comparison)

Sensitivity 3

Symptomatic COVID-19

Those not meeting case definition

2 weeks before illness (cases) and 2 weeks before questionnaire completion (comparison group)

Sensitivity 4

Any acute RTI lasting 3 days or more

Those not meeting case definition

2 weeks before illness (cases) and 2 weeks before questionnaire completion (comparison group)

  1. aProbable COVID-19: Positive COVID-19 ‘nose or throat swab’ test AND/OR self-reported respiratory illness (of 3 or more days) occurring during the pandemic period that was associated with fever and loss of smell and/or taste [10]
  2. Suspected COVID-19: Positive COVID-19 ‘nose or throat swab’ test AND/OR self-reported respiratory illness (of 3 or more days) occurring during the pandemic period that was associated with loss or smell and/or taste OR fever and cough OR three or more of: fever, cough, fatigue, headache, myalgia, sore throat, runny or blocked nose, shortness of breath, nausea or vomiting, diarrhoea [11]
  3. Symptomatic COVID-19: Those meeting the criteria for Susptected COVID-19, but excluding those with a positive nose or throat swab who did not report having a respiratory illness lasting 3 days or more